Status:
COMPLETED
Influence of Luteolin for Two Weeks on Memory in Healthy Subjects
Lead Sponsor:
Prof. Dominique de Quervain, MD
Conditions:
Memory
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn about the effect of the dietary supplement luteolin in healthy people. The main question it aims to answer is: Does luteolin have an influence on memory fun...
Eligibility Criteria
Inclusion
- healthy
- male or female
- able to give written informed consent as documented by signature
- Aged: 18 to 40 years
- normotensive (BP 90/60mmHg to 140/90mmHg)
- BMI ≤ 30 kg/m2
Exclusion
- bodyweight \<50 kg
- pregnant or lactating women
- intention to become pregnant during the course of the study
- known or suspected non-compliance, drug or alcohol abuse
- MADRS-S total score \> 12 or MADRS-S item 9 \>1
- inability to follow the procedures of the study, e.g. due to language problems, psychological disorders
- participation in another study with investigational drug within the 30 days preceding and during the present study
- participation in one of our previous studies using the same memory tests in the past 2 years or participation in our first luteolin study in 2020
- enrolment of the investigator, his/her family members, employees and other dependent persons
Key Trial Info
Start Date :
November 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06047899
Start Date
November 28 2023
End Date
May 2 2024
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Basel, Division of Cognitive Neuroscience
Basel, Canton of Basel-City, Switzerland, 4055